Understand the source comparison
Is DSIP Legal: Research Classification Comparison
FDA (United States) Investigational peptide, not FDA-approved Legal when sold explicitly for research purposes with proper labeling Illegal. No approved therapeutic indication or prescription pathway Must be labeled "Not for Human Consumption"; supplier must n
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- FDA (United States)
- Investigational peptide, not FDA-approved
- Legal when sold explicitly for research purposes with proper labeling
- Illegal. No approved therapeutic indication or prescription pathway
- Must be labeled "Not for Human Consumption"; supplier must not make therapeutic claims
- DEA (United States)
- Not a controlled substance under CSA
- No scheduling restrictions; no DEA registration required
- N/A. Not scheduled
- No specific DEA compliance requirement beyond standard research protocols
- Health Canada
- Controlled substance requiring authorization
- Legal with appropriate research permits and institutional oversight
- Illegal without prescription; no approved indication exists
- Import permit required; institutional research ethics board approval
- EMA (European Union)
- Unregulated research compound when not marketed for therapeutic use
- Legal in most EU member states for laboratory research
- Illegal as unapproved medicine
- Supplier compliance with local distribution laws; no medicinal claims
- TGA (Australia)
- Prescription-only substance classification
- Legal with TGA import approval and institutional research authorization
- Illegal without prescription; no therapeutic goods registration
- Special importation permit required even for research use